Zevra Therapeutics (ZVRA) Receivables (2016 - 2026)
Zevra Therapeutics (ZVRA) recorded Receivables of $22.49 million in Q2 2026, up 23.1% from $18.27 million a year earlier and up 1.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Receivables (2016 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics reported Receivables of $23.26 million, up 114.5% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of 53.6% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $10.84 million in FY2024 (-41.8%), $18.64 million in FY2023 (+98.0%), $9.41 million in FY2022 (+475.7%) and $1.64 million in FY2021 (-39.8%).
- Quarterly Receivables has ranged from $1.62 million in Q3 2021 to $23.26 million in Q4 2025 over the past five years.
- On a year-over-year basis, Receivables has increased for six consecutive quarters, with growth averaging 52.7% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 737.9% in Q3 2022, against a decline of 49.2% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $22.1 million (Q1 2026), $23.26 million (Q4 2025) and $16.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Zevra Therapeutics | 612.56 Mn | -200.15 Mn | 38.18 Mn | 22.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.49 Mn |
| Mar 31, 2026 | 22.10 Mn |
| Dec 31, 2025 | 23.26 Mn |
| Sep 30, 2025 | 16.84 Mn |
| Jun 30, 2025 | 18.27 Mn |
| Mar 31, 2025 | 12.62 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Sep 30, 2024 | 7.79 Mn |
| Jun 30, 2024 | 8.95 Mn |
| Mar 31, 2024 | 8.31 Mn |
| Dec 31, 2023 | 18.64 Mn |
| Sep 30, 2023 | 9.93 Mn |
| Jun 30, 2023 | 14.03 Mn |
| Mar 31, 2023 | 16.34 Mn |
| Dec 31, 2022 | 9.41 Mn |
| Sep 30, 2022 | 13.57 Mn |
| Jun 30, 2022 | 5.94 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.62 Mn |
API Access
Zevra Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();